Letter to the Editor
July 2001

Continuing Treatment With Novel Antipsychotic Drugs Despite Leukopenia or Thrombocytopenia

Author Affiliations

Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001

Arch Gen Psychiatry. 2001;58(7):706-707. doi:10.1001/archpsyc.58.7.706

Novel antipsychotic medications are increasingly being used as first-line agents in treating schizophrenia as well as other psychotic disorders.1 Although olanzapine and quetiapine fumarate have not been reported to cause notable neutropenia, and blood monitoring is not required as is with clozapine, the following is a report of a case of persistent neutropenia in a patient treated with both agents.

First Page Preview View Large
First page PDF preview
First page PDF preview